Indication
Mild persistent asthma
Mild persistent asthma is a clinical severity classification of chronic asthma affecting the lower respiratory tract in pediatric and adult populations. Read more about Mild persistent asthma
45 drugs 37 manufacturers
Drugs that treat it
Common Mild persistent asthma therapies.
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
THEO-24 (theophylline anhydrous)
THEOPHYLLINE (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMild persistent asthma is a clinical severity classification of chronic asthma affecting the lower respiratory tract in pediatric and adult populations.
It is pathophysiologically driven by chronic airway inflammation, bronchial hyperresponsiveness, and variable airflow limitation.
Clinically, it is defined by daytime respiratory symptoms—such as wheezing, dyspnea, chest tightness, or cough—occurring more than twice per week but less than daily, and nighttime awakenings occurring three to four times per month.
Patients typically experience minor interference with normal daily activities and demonstrate preserved baseline pulmonary function, generally maintaining a forced expiratory volume in one second (FEV1) of at least 80 percent of predicted.
- nih.gov
Mild persistent asthma is a clinical severity classification of chronic asthma affecting the lower respiratory tract in pediatric and adult populations It is pathophysiologically driven by chronic airway inflammation, bronchial hyperresponsiveness, and variable airflow limitation
- uofmhealth.org
Mild persistent asthma is a clinical severity classification of chronic asthma affecting the lower respiratory tract in pediatric and adult populations Clinically, it is defined by daytime respiratory symptoms—such as wheezing, dyspnea, chest tightness, or cough—occurring more than twice per week but less than daily, and nighttime awakenings occurring three to four times per month
- nih.gov
It is pathophysiologically driven by chronic airway inflammation, bronchial hyperresponsiveness, and variable airflow limitation
- nih.gov
Clinically, it is defined by daytime respiratory symptoms—such as wheezing, dyspnea, chest tightness, or cough—occurring more than twice per week but less than daily, and nighttime awakenings occurring three to four times per month Patients typically experience minor interference with normal daily activities and demonstrate preserved baseline pulmonary function, generally maintaining a forced expiratory volume in one second (FEV1) of at least 80 percent of predicted
- healthline.com
Clinically, it is defined by daytime respiratory symptoms—such as wheezing, dyspnea, chest tightness, or cough—occurring more than twice per week but less than daily, and nighttime awakenings occurring three to four times per month
- nih.gov
Patients typically experience minor interference with normal daily activities and demonstrate preserved baseline pulmonary function, generally maintaining a forced expiratory volume in one second (FEV1) of at least 80 percent of predicted
Personalize your experience
Follow Mild persistent asthma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.